Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0252708002
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02514222 | INSTITUTO GRIFOLS S.A. | VISTASEAL | Human | Yes | Schedule D | 2 | FIBRINOGEN (HUMAN) | 80 MG / 1 ML |
Marketed | 02514230 | INSTITUTO GRIFOLS S.A. | VISTASEAL | Human | Yes | Schedule D | 2 | FIBRINOGEN (HUMAN) | 160 MG / 2 ML |
Approved | 02514249 | INSTITUTO GRIFOLS S.A. | VISTASEAL | Human | Yes | Schedule D | 2 | FIBRINOGEN (HUMAN) | 240 MG / 3 ML |
Marketed | 02514257 | INSTITUTO GRIFOLS S.A. | VISTASEAL | Human | Yes | Schedule D | 2 | FIBRINOGEN (HUMAN) | 400 MG / 5 ML |
Application information
Related information
Contact us
Version 4.0.3